MedTrace Logo

Study of the Spread of COVID-19 in Saint Petersburg, Russia

NCT04406038 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1038

Last updated 2023-11-08

No results posted yet for this study

Summary

Seroprevalence study of COVID-19 in Saint Petersburg, Russia is a regional longitudinal cohort study aiming to evaluate the spread dynamics of the COVID-19 disease in the population of Saint Petersburg. Clinically asymptomatic adults are sampled from the population using random digit dialing and tested for the presence of SARS-CoV-2-specific antibodies in the blood serum. Data collection and serial sampling of the same individuals spans four weeks and is conducted every two weeks in order to understand both the spread of the virus in the population.

Conditions

  • COVID19

Sponsors & Collaborators

  • European University at St. Petersburg

    lead OTHER

Principal Investigators

  • Lubov Barabanova, MD · Clinic "Scandinavia"

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-27
Primary Completion
2022-10-28
Completion
2023-11-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04406038 on ClinicalTrials.gov